Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ependymoma × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 488 Leukemia 246 Precursor Cell Lymphoblastic Leukemia-Lymphoma 198 Lymphoma 133 Myelodysplastic Syndromes 95 Burkitt Lymphoma 77 Lymphoma, Non-Hodgkin 74 Leukemia, Monocytic, Acute 74 Congenital Abnormalities 73 Leukemia, Myelomonocytic, Acute 71 Leukemia, Erythroblastic, Acute 66 Lymphoma, Large B-Cell, Diffuse 65 Leukemia, Megakaryoblastic, Acute 63 Recurrence 59 Lymphoma, Mantle-Cell 58 Lymphoma, Follicular 42 Hodgkin Disease 40 Leukemia, Myelomonocytic, Chronic 39 Leukemia, Biphenotypic, Acute 37 Lymphoma, Large-Cell, Immunoblastic 34 Anemia, Refractory, with Excess of Blasts 30 Myeloproliferative Disorders 29 Leukemia, Lymphocytic, Chronic, B-Cell 29 Blast Crisis 29 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24 Lymphoma, B-Cell, Marginal Zone 21 Leukemia, Myeloid, Chronic-Phase 21 Multiple Myeloma 20 Leukemia, Eosinophilic, Acute 19

Interventions

Temozolomide 24 Magnetic Resonance Spectroscopy 16 Etoposide 13 Cyclophosphamide 12 Filgrastim 10 Bevacizumab 9 Radiotherapy 8 Carboplatin 8 Biopsy 8 X-Rays 6 Specimen Handling 6 Phantoms, Imaging 6 Cisplatin 6 Thiotepa 5 Nuclear Medicine Department, Hospital 5 Nivolumab 5 Irinotecan 5 Carmustine 5 sargramostim 4 Vincristine 4 Radiation 4 Peripheral Blood Stem Cell Transplantation 4 Methotrexate 4 Erlotinib Hydrochloride 4 etoposide phosphate 3 Surveys and Questionnaires 3 Lapatinib 3 Granulocyte Colony-Stimulating Factor 3 Gadolinium DTPA 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡